Tedizolid measures up to linezolid for bacterial pneumonia mortality, but not clinical cure
05 Apr 2021
byJairia Dela Cruz
In the treatment of patients with gram-positive hospital-acquired or ventilator-associated bacterial pneumonia, tedizolid works as well as linezolid in terms of 28-day all-cause mortality but not investigator-assessed clinical response, according to the results of a phase III trial.
Tedizolid measures up to linezolid for bacterial pneumonia mortality, but not clinical cure
05 Apr 2021
